Our News

Capital increase a great success

€23m raised by full exercise of the extension clause Strong subscription from French and international institutional investors and individuals Offer subscribed 143% Evry (France) July 11, 2013 – Global Bioenergies…

Frédéric Pâques appointed as CTO

Evry June 10th, 2013 – Frédéric Pâques, former Scientific Director at Cellectis, joins Global Bioenergies (NYSE Alternext Paris: ALGBE) as Chief Technology Officer. Philippe Marlière, co-founder and President of Global…